AC Immune S.A.
ACIU News Today: Stay Updated with the Latest AC Immune S.A. News in Real Time
Find ACIU news now at Meyka AI. Stay informed with the latest AC Immune S.A. stocks updates, including price news, market analysis, and expert insights.
EQ Upgraded to Buy by B. Riley on April 16, 2026
B. Riley initiated coverage of Equillium (EQ) with a Buy rating on April 16, 2026, marking the first analyst upgrade for the biotech stock.
ACIU CEO Pfeifer Sells 20K Shares at $3.14 on April 15, 2026
AC Immune CEO Andrea Pfeifer sold 20,000 shares at $3.14 per share on April 15, 2026. SEC filings reveal insider selling activity.
Eviction Crisis April 16: Legal Aid Battles Rising Rates
Houston’s eviction rate doubles New York’s. Legal aid and hospital evictions over $25M highlight systemic housing challenges.
LULU Stock April 16: Texas PFAS Investigation Deepens
Lululemon stock drops 4% as Texas investigates PFAS chemicals in yoga wear. What this means for LULU investors and athleisure.
IMMP stock surges 97% on FDA orphan drug designation for efti
IMMP stock jumps 97% after FDA grants orphan drug designation for eftilagimod alfa in soft tissue sarcoma treatment.
Lululemon Stock April 15: Texas PFAS Investigation Deepens
Lululemon addresses Texas PFAS investigation into forever chemicals in activewear; company phased out chemicals in 2023.
Honda to Recall 440,000+ U.S. Vehicles Over Airbag Deployment Issue
Honda is recalling more than 440,000 vehicles in the United States after regulators identified a software issue that could cause airbags to deploy unexpectedly. The recall affects 440,830 Honda Odyssey minivans, making it one of the company’s most notable U.S. safety recalls of the year. The announcement has drawn attention from consumers, investors, and the…
IPH.PA stock surges 13.7% on April 14 as biotech gains momentum
IPH.PA stock jumps 13.7% to €1.36 on EURONEXT. Innate Pharma gains as biotech sector shows strength with clinical pipeline progress.
Publicis Reports 4.5% Organic Revenue Growth, Strengthens Leadership in US and China Markets
Publicis has delivered another strong quarter, reporting 4.5 percent organic net revenue growth in the first quarter of 2026 as the global advertising and marketing giant continues to outperform many of its industry peers. The results reinforce the company’s position as one of the strongest players in global advertising while highlighting the success of its…